India's pharmaceutical exports grew by approximately 2% to surpass $31 billion in the 2025–26 financial year (FY26), reinforcing the country's position as one of the world's leading generic drug suppliers. The gains came despite a sharp decline in exports recorded during March, which tempered overall growth for the fiscal period. The figures highlight India's continued resilience in global pharma trade even as monthly volatility and external market pressures pose ongoing challenges to the sector.